CD8A and neoplasm: Tissue originating cross-presenting DCs were shown to be required to migrate from the tumor microenvironment (TME), loaded with antigens from the tumor, toward the draining lymph node, to induce CD8 T cell-dependent delay of tumor outgrowth.